Antongiulio Faggiano

Pubblicazioni

Titolo Pubblicato in Anno
Diagnosis of Flier's syndrome in a patient with nondiabetic hypoglycemia. a case report and critical appraisal of the literature ENDOCRINE 2020
Selenium supplementation in the management of thyroid autoimmunity during pregnancy: results of the "SERENA study", a randomized, double-blind, placebo-controlled trial ENDOCRINE 2019
Therapeutic sequences in patients with grade 1−2 neuroendocrine tumors (NET): an observational multicenter study from the ELIOS group ENDOCRINE 2019
Bone metastases in neuroendocrine neoplasms: from pathogenesis to clinical management CANCERS 2019
Immune checkpoint blockade for Merkel cell carcinoma: actual findings and unanswered questions JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY 2019
Tumour type and size are prognostic factors in gastric neuroendocrine neoplasia: a multicentre retrospective study DIGESTIVE AND LIVER DISEASE 2019
Lanreotide therapy vs active surveillance in MEN1-related pancreatic neuroendocrine tumors < 2 centimeters THE JOURNAL OF CLINICAL ENDOCRINOLOGY AND METABOLISM 2019
Prognostic impact of tumour burden in stage IV neuroendocrine neoplasia: a comparison between pancreatic and gastrointestinal localizations PANCREATOLOGY 2019
Prognosis of malignant pheochromocytoma and paraganglioma (MAPP-PronO study): a European network for the study of adrenal tumors retrospective study THE JOURNAL OF CLINICAL ENDOCRINOLOGY AND METABOLISM 2019
Human exposure to bisphenol AF and diethylhexylphthalate increases susceptibility to develop differentiated thyroid cancer in patients with thyroid nodules CHEMOSPHERE 2019
A rare rarity: neuroendocrine tumor of the esophagus CRITICAL REVIEWS IN ONCOLOGY/HEMATOLOGY 2019
Clinical presentation and management of patients with primary hyperparathyroidism in Italy JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION 2018
The Zollinger-Ellison syndrome: is there a role for somatostatin analogues in the treatment of the gastrinoma? ENDOCRINE 2018
HypoparaNet: A Database of Chronic Hypoparathyroidism Based on Expert Medical-Surgical Centers in Italy CALCIFIED TISSUE INTERNATIONAL 2018
Sunitinib in patients with pre-treated pancreatic neuroendocrine tumors: a real-world study PANCREATOLOGY 2018
Chromogranin a as circulating marker for diagnosis and management of neuroendocrine neoplasms: More flaws than fame ENDOCRINE-RELATED CANCER 2018
Emerging multitarget tyrosine kinase inhibitors in the treatment of neuroendocrine neoplasms ENDOCRINE-RELATED CANCER 2018
Pasireotide in the treatment of neuroendocrine tumors: a review of the literature ENDOCRINE-RELATED CANCER 2018
Diabetes and pancreatic neuroendocrine tumours: which interplays, if any? CANCER TREATMENT REVIEWS 2018
Heterogeneity of duodenal neuroendocrine tumors: an Italian multi-center experience ANNALS OF SURGICAL ONCOLOGY 2018

ERC

  • LS2_1
  • LS2_14
  • LS4_4
  • LS4_9
  • LS4_12
  • LS7_4
  • LS7_8
  • LS7_10
  • LS7_14

KET

  • Life-science technologies & biotechnologies

Interessi di ricerca

La principale area di ricerca sono è l'endocrinologia oncologica con numerose pubblicazioni e progetti clinici e traslazionali sulle neoplasie neuroendocrine, le neoplasie tiroidee, l'iperparatiroidismo, i tumori ipofisari, i feocromocitomi e paragangliomi, le sindromi neoplastiche genetiche multiendocrine. In tale ambito l'interesse di ricerca va dagli studi epidemiologici e di valutazione di fattori prognostici clinici e molecolari, studi sul ruolo della sindrome metabolica, della nutrizione e dei fatoori ambientali sulle neoplasie endocrine e neuroendocrine, studi genetici (ricerca nuove mutazioni, VUS, screening genetico, analisi NGS), studi diagnostici sulla diagnosi biochimica e ormonale e la diagnosi di imaging, studi terapeutici sull'efficacia e tossicità di farmaci biologici come analoghi della somatostatina, dopamino-agonisti, inibitori di mTOR, inibitori tirosino-chinasici. Più di recente interesse per l'andrologia, i tumori testicolari e le malattie genetiche della sfera andrologica

Keywords

neuroendocrine tumors (NETs)
Neuroendocrine neoplasms
multiple endocrine neoplasia type 1
Multiple Endocrine Neoplasia Type 2a/drug therapy
medullary thyroid cancer
Hyperparathyroidism
endocrine disrupting chemicals
Endocrine Gland Neoplasms
Endocrine function
andrological health
Pheochromocytoma

© Università degli Studi di Roma "La Sapienza" - Piazzale Aldo Moro 5, 00185 Roma